Bishop John E sold Ardelyx Inc. ($ARDX) shares on the open market three times in the last year, totaling about $18,600. His most recent sale was on February 20, 2026. These transactions rank 11,074th out of 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 trades. He made no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | ARDELYX, INC. | $ARDX | Bishop John E | See Remarks | S | Common Stock | 386 | $5.71 | 339,152.0000 | 245,247,427 | 0.11% | 0.00% |
| Feb. 20, 2026 | ARDELYX, INC. | $ARDX | Bishop John E | See Remarks | S | Common Stock | 2792 | $5.87 | 339,538.0000 | 245,247,427 | 0.82% | 0.00% |
| Feb. 20, 2026 | ARDELYX, INC. | $ARDX | Bishop John E | See Remarks | S | Common Stock | 1 | $5.70 | 339,151.0000 | 245,247,427 | 0.00% | 0.00% |
| Jan. 23, 2026 | ARDELYX, INC. | $ARDX | Bishop John E | See Remarks | A | Stock Option (Right to Buy) | 186500 | $0.00 | 186,500.0000 | 242,974,306 | 9999.99% | 0.08% |
| Jan. 23, 2026 | ARDELYX, INC. | $ARDX | Bishop John E | See Remarks | A | Common Stock | 124330 | $0.00 | 342,330.0000 | 242,974,306 | 57.03% | 0.05% |
| Jan. 30, 2024 | Lyra Therapeutics, Inc. | $LYRA | Bishop John E | Chief Technology Officer | A | Stock Options | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2023 | Lyra Therapeutics, Inc. | $LYRA | Bishop John E | Chief Technology Officer | A | Stock Option | 220000 | $0.00 | 220,000.0000 | 0 | 9999.99% | 0.00% |